nach oben

Erschienen in:

07.08.2024 | editorial

Cardiovascular (side) effects of cannabis

verfasst von: Julia Mascherbauer, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 19-20/2024

Einloggen, um Zugang zu erhalten

Auszug

Within most of the European Union cannabis remains illegal; however, recently many countries have begun to legalize cannabis for limited (therapeutic) purposes [1]. With continuing cannabis decriminalization and legalization, the association between cannabis exposure and incident side effects has emerged as an important safety issue. In particular, the relationship between cannabis use and cardiovascular (CV) side effects is an area of growing interest. …

Nächster Artikel The establishment of orthopedics in Croatia

European Monitoring Centre for Drugs and Drug Addiction. Cannabis laws in Europe. 2023. https://www.emcdda.europa.eu/publications/faq/cannabis-laws-europe-questions-and-answers-for-policymaking_en (Created 06.2023). Accessed 9 Nov 2023.

Cohen K, Weizman A, Weinstein A. Positive and negative effects of cannabis and Cannabinoids on health. Clin Pharmacol Ther. 2019;105(5):1139–47. https://doi.org/10.1002/cpt.1381.CrossRefPubMed

Page RL 2nd, Allen LA, Kloner RA, Carriker CR, Martel C, Morris AA, Piano MR, Rana JS, Saucedo JF, American Heart Association Clinical Pharmacology Committee, Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Lifestyle and Cardiometabolic Health, Council on Quality of Care and Outcomes Research. Medical Marijuana, recreational Cannabis, and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2020;142(10):e131–e52. https://doi.org/10.1161/CIR.0000000000000883.CrossRefPubMed

Lu HC, Mackie K. Review of the endocannabinoid system. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607–15. https://doi.org/10.1016/j.bpsc.2020.07.016.CrossRefPubMed

Pacher P, Steffens S, Haskó G, Schindler TH, Kunos G. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol. 2018;15(3):151–66. https://doi.org/10.1038/nrcardio.2017.130.CrossRefPubMed

Dabiri AE, Kassab GS. Effects of cannabis on cardiovascular system: the good, the bad, and the many unknowns. Med Cannabis Cannabinoids. 2021;4(2):75–85. https://doi.org/10.1159/000519775.CrossRefPubMedCentral

DeFilippis EM, Bajaj NS, Singh A, Malloy R, Givertz MM, Blankstein R, Bhatt DL, Vaduganathan M. Marijuana use in patients with cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2020;75(3):320–32. https://doi.org/10.1016/j.jacc.2019.11.025.CrossRefPubMedPubMedCentral

Rezkalla S, Kloner RA. Cardiovascular effects of marijuana. Trends Cardiovasc Med. 2019;29(7):403–7. https://doi.org/10.1016/j.tcm.2018.11.004.CrossRef

Ii PRL. Cannabis by any name does not smell as sweet: potential cardiovascular events with medical cannabis. Eur Heart J. 2024;45(6):485–7. https://doi.org/10.1093/eurheartj/ehad848.CrossRef

10.

Holt A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, Schjerning AM, Rasmussen VP, Torp-Pedersen C, Gislason GH, Schou M, McGettigan P, Lamberts M. Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study. Eur Heart J. 2024;45(6):475–84. https://doi.org/10.1093/eurheartj/ehad834.CrossRef

11.

Mukamal KJ, Maclure M, Muller JE, Mittleman MA. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J. 2008;155(3):465–70. https://doi.org/10.1016/j.ahj.2007.10.049.CrossRefPubMedPubMedCentral

12.

Frost L, Mostofsky E, Rosenbloom JI, Mukamal KJ, Mittleman MA. Marijuana use and long-term mortality among survivors of acute myocardial infarction. Am Heart J. 2013;165(2):170–5. https://doi.org/10.1016/j.ahj.2012.11.007.CrossRefPubMed

13.

Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–9. https://doi.org/10.1161/01.cir.103.23.2805.CrossRefPubMed

14.

Pacher P, Mukhopadhyay P, Mohanraj R, Godlewski G, Bátkai S, Kunos G. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Hypertension. 2008;52(4):601–7. https://doi.org/10.1161/HYPERTENSIONAHA.105.063651.CrossRefPubMed

15.

Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389–462. https://doi.org/10.1124/pr.58.3.2.CrossRefPubMed

16.

Bedi G, Cooper ZD, Haney M. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers. Addict Biol. 2013;18(5):872–81. https://doi.org/10.1111/j.1369-1600.2011.00427.x.CrossRefPubMed

17.

Kalla A, Krishnamoorthy PM, Gopalakrishnan A, Figueredo VM. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample. J Cardiovasc Med. 2018;19(9):480–4. https://doi.org/10.2459/JCM.0000000000000681.CrossRef

18.

Rumalla K, Reddy AY, Mittal MK. Recreational Marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States. J Neurol Sci. 2016;364:191–6. https://doi.org/10.1016/j.jns.2016.01.066.CrossRefPubMed

19.

Jouanjus E, Lapeyre-Mestre M, Micallef J, French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications*. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3(2):e638. https://doi.org/10.1161/JAHA.113.000638.CrossRefPubMedCentral

Titel: Cardiovascular (side) effects of cannabis
verfasst von: Julia Mascherbauer, MD
Publikationsdatum: 07.08.2024
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 19-20/2024
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-024-02403-8

Femoral hibernoma: unique intraosseous tumor

images in clinical medicine

Clinical results of acetabular fracture treatment with hybrid fixation by anterior and posterior approach

original article

Wir stellen vor: ÖGP Grants und Preisträger*innen 2024

mitteilungen der österreichischen gesellschaft für pneumologie

Esophageal perforation with near fatal mediastinitis secondary to Th3 fracture

Open Access
case report

MUW researcher of the month

MUW researcher of the month

Broström ankle ligament repair augmented with suture tape

original article

Springer Medizin Österreich

Cardiovascular (side) effects of cannabis

Auszug

Weitere Artikel der Ausgabe 19-20/2024

Femoral hibernoma: unique intraosseous tumor

Clinical results of acetabular fracture treatment with hybrid fixation by anterior and posterior approach

Wir stellen vor: ÖGP Grants und Preisträger*innen 2024

Esophageal perforation with near fatal mediastinitis secondary to Th3 fracture

MUW researcher of the month

Broström ankle ligament repair augmented with suture tape

Springer Medizin Österreich

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Femoral hibernoma: unique intraosseous tumor

Clinical results of acetabular fracture treatment with hybrid fixation by anterior and posterior approach

Wir stellen vor: ÖGP Grants und Preisträger*innen 2024

Esophageal perforation with near fatal mediastinitis secondary to Th3 fracture

MUW researcher of the month

Broström ankle ligament repair augmented with suture tape